Skip to content
2000
Volume 28, Issue 11
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Aim

Disulfidptosis is a new metabolic-related regulated cell death associated with cancer growth. This study aimed to investigate the molecular mechanisms associated with disulfidptosis in skin cutaneous melanoma (SKCM) and establish a disulfidptosis-related gene signature for prognostic prediction in SKCM.

Methods

Disulfidptosis-associated genes were identified from RNA-seq data of SKCM. A risk score signature was developed and validated through univariate Cox and LASSO analyses. Additionally, the immune microenvironment related to the risk score signature was investigated. Finally, a disulfidptosis-related genes-transcription factor -miRNA network was developed, and the expression levels of five disulfidptosis-related genes were initially verified in SKCM cell lines.

Results

A total of 107 disulfidptosis-related differentially expressed genes in SKCM samples were identified. A ten-disulfidptosis-gene signature was established, including , and The SKCM samples were divided into high- and low-risk groups, of which samples in the low-risk group showed better survival performance. The receiver operating characteristic curve analysis confirmed the good potency of the disulfidptosis-related gene prognostic model. Except for , the other nine genes were positively related with T cell CD8+, T cell CD4+ memory activated, T cell gamma delta, NK cell activated, and macrophage M1, and they were all negatively related with NK cell resting, macrophage M0, macrophage M2, and mast cell activated. Finally, we verified downregulated levels of SOCS1 and DEFB1 and upregulated CXCR3, BIN2, and CCL3L3 in A875 and A375.

Conclusion

We successfully established ten disulfidptosis-related genes' prediction prognostic signatures for SKCM patients.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073307469240528065718
2024-06-14
2025-12-17

  • From This Site

    /content/journals/cchts/10.2174/0113862073307469240528065718
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PegaF. MomenN.C. StreicherK.N. Leon-RouxM. NeupaneS. Schubauer-BeriganM.K. SchüzJ. BakerM. DriscollT. Guseva CanuI. KiiverH.M. LiJ. Nwanaji-EnweremJ.C. TurnerM.C. ViegasS. VilleneuveP.J. Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000–2019: A systematic analysis from the WHO/ILO joint estimates of the work-related burden of disease and injury.Environ. Int.202318110822610.1016/j.envint.2023.108226 37945424
     [Google Scholar]
  2. ArnoldM. SinghD. LaversanneM. VignatJ. VaccarellaS. MeheusF. CustA.E. de VriesE. WhitemanD.C. BrayF. Global burden of cutaneous melanoma in 2020 and projections to 2040.JAMA Dermatol.2022158549550310.1001/jamadermatol.2022.0160 35353115
     [Google Scholar]
  3. MollicaV. RizzoA. MarchettiA. TateoV. TassinariE. RoselliniM. MassafraR. SantoniM. MassariF. The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: The MOUSEION-06 study.Clin. Exp. Med.20232385039504910.1007/s10238‑023‑01159‑1 37535194
     [Google Scholar]
  4. RizzoA. Nivolumab plus ipilimumab in melanoma brain metastases.Lancet Oncol.2022232e5210.1016/S1470‑2045(22)00010‑9 35114121
     [Google Scholar]
  5. GuvenD.C. SahinT.K. ErulE. RizzoA. RicciA.D. AksoyS. YalcinS. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.Front. Mol. Biosci.20229103912110.3389/fmolb.2022.1039121 36533070
     [Google Scholar]
  6. RizzoA. MollicaV. TateoV. TassinariE. MarchettiA. RoselliniM. De LucaR. SantoniM. MassariF. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: The MOUSEION-05 study.Cancer Immunol. Immunother.20237261381139410.1007/s00262‑023‑03366‑x 36695827
     [Google Scholar]
  7. LiuX. OlszewskiK. ZhangY. LimE.W. ShiJ. ZhangX. ZhangJ. LeeH. KoppulaP. LeiG. ZhuangL. YouM.J. FangB. LiW. MetalloC.M. PoyurovskyM.V. GanB. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.Nat. Cell Biol.202022447648610.1038/s41556‑020‑0496‑x 32231310
     [Google Scholar]
  8. LiX.J. WenR. WenD.Y. LinP. PanD.H. ZhangL.J. HeY. ShiL. QinY.Y. LaiY.H. LaiJ.N. YangJ.L. LaiQ.Q. WangJ. MaJ. YangH. PangY.Y. Downregulation of miR 193a 3p via targeting cyclin D1 in thyroid cancer.Mol. Med. Rep.20202232199221810.3892/mmr.2020.11310 32705210
     [Google Scholar]
  9. ZhaoY. WeiY. FanL. NieY. LiJ. ZengR. LiJ. ZhanX. LeiL. KangZ. LiJ. ZhangW. YangZ. Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.Mol. Med.202329114510.1186/s10020‑023‑00739‑x 37884883
     [Google Scholar]
  10. SatamH. JoshiK. MangroliaU. WaghooS. ZaidiG. RawoolS. ThakareR.P. BandayS. MishraA.K. DasG. MaloniaS.K. Next-generation sequencing technology: Current trends and advancements.Biology202312799710.3390/biology12070997 37508427
     [Google Scholar]
  11. MaghsoudiS. Taghavi ShahrakiB. RamehF. NazarabiM. FatahiY. AkhavanO. RabieeM. MostafaviE. LimaE.C. SaebM.R. RabieeN. A review on computer‐aided chemogenomics and drug repositioning for rational COVID ‐19 drug discovery.Chem. Biol. Drug Des.2022100569972110.1111/cbdd.14136 36002440
     [Google Scholar]
  12. AlimirzaeiF. KieslichC.A. Machine learning models for predicting membranolytic anticancer peptides.Computer Aided Chemical Engineering KokossisA.C. GeorgiadisM.C. PistikopoulosE. Elsevier20235226912696
     [Google Scholar]
  13. TabakhiS. SuvonM.N.I. AhadianP. LuH. Multimodal learning for multi-omics: A survey.World Sci. Ann. Rev. Artif. Intell.20231225000410.1142/S2811032322500047
     [Google Scholar]
  14. RobertC. GautheretD. Multi-omics prediction in melanoma immunotherapy: A new brick in the wall.Cancer Cell2022401141610.1016/j.ccell.2021.12.008 35016026
     [Google Scholar]
  15. CirenajwisH. EkedahlH. LaussM. HarbstK. CarneiroA. EnokssonJ. RosengrenF. Werner-HartmanL. TörngrenT. KvistA. FredlundE. BendahlP.O. JirströmK. LundgrenL. HowlinJ. BorgÅ. Gruvberger-SaalS.K. SaalL.H. NielsenK. RingnérM. TsaoH. OlssonH. IngvarC. StaafJ. JönssonG. Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.Oncotarget2015614122971230910.18632/oncotarget.3655 25909218
     [Google Scholar]
  16. CabritaR. LaussM. SannaA. DoniaM. Skaarup LarsenM. MitraS. JohanssonI. PhungB. HarbstK. Vallon-ChristerssonJ. van SchoiackA. LövgrenK. WarrenS. JirströmK. OlssonH. PietrasK. IngvarC. IsakssonK. SchadendorfD. SchmidtH. BastholtL. CarneiroA. WargoJ.A. SvaneI.M. JönssonG. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.Nature2020577779156156510.1038/s41586‑019‑1914‑8 31942071
     [Google Scholar]
  17. BarrettT. TroupD.B. WilhiteS.E. LedouxP. EvangelistaC. KimI.F. TomashevskyM. MarshallK.A. PhillippyK.H. ShermanP.M. MuertterR.N. HolkoM. AyanbuleO. YefanovA. SobolevaA. NCBI GEO: Archive for functional genomics data sets--10 years on.Nucleic Acids Res.201139DatabaseD1005D101010.1093/nar/gkq1184 21097893
     [Google Scholar]
  18. WangT. GuoK. ZhangD. WangH. YinJ. CuiH. WuW. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile.Int. Immunopharmacol.202312011036810.1016/j.intimp.2023.110368 37247499
     [Google Scholar]
  19. ZhongZ. WangY. YinJ. NiS. LiuW. GengR. LiuJ. BaiJ. YuH. Identification of specific cervical cancer subtypes and prognostic gene sets in tumor and nontumor tissues based on GSVA analysis.J. Oncol.2022202211710.1155/2022/6951885 36284631
     [Google Scholar]
  20. CampR.L. Dolled-FilhartM. RimmD.L.D.L. X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.Clin. Cancer Res.200410217252725910.1158/1078‑0432.CCR‑04‑0713 15534099
     [Google Scholar]
  21. WangP. WangY. HangB. ZouX. MaoJ.H. A novel gene expression-based prognostic scoring system to predict survival in gastric cancer.Oncotarget2016734553435535110.18632/oncotarget.10533 27419373
     [Google Scholar]
  22. LangfelderP. HorvathS. WGCNA: An R package for weighted correlation network analysis.BMC Bioinformatics20089155910.1186/1471‑2105‑9‑559 19114008
     [Google Scholar]
  23. RitchieM.E. PhipsonB. WuD. HuY. LawC.W. ShiW. SmythG.K. limma powers differential expression analyses for RNA-sequencing and microarray studies.Nucleic Acids Res.2015437e4710.1093/nar/gkv007 25605792
     [Google Scholar]
  24. HuangD.W. ShermanB.T. LempickiR.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.Nat. Protoc.200941445710.1038/nprot.2008.211 19131956
     [Google Scholar]
  25. HuangD.W. ShermanB.T. LempickiR.A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists.Nucleic Acids Res.200937111310.1093/nar/gkn923 19033363
     [Google Scholar]
  26. MayrA. SchmidM. Boosting the concordance index for survival data--a unified framework to derive and evaluate biomarker combinations.PLoS One201491e8448310.1371/journal.pone.0084483 24400093
     [Google Scholar]
  27. SubramanianA. TamayoP. MoothaV.K. MukherjeeS. EbertB.L. GilletteM.A. PaulovichA. PomeroyS.L. GolubT.R. LanderE.S. MesirovJ.P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles.Proc. Natl. Acad. Sci. USA200510243155451555010.1073/pnas.0506580102 16199517
     [Google Scholar]
  28. ChenB. KhodadoustM.S. LiuC.L. NewmanA.M. AlizadehA.A. Profiling tumor infiltrating immune cells with CIBERSORT.Methods Mol. Biol.2018171124325910.1007/978‑1‑4939‑7493‑1_12 29344893
     [Google Scholar]
  29. EberlyL.E. Correlation and simple linear regression.Methods Mol. Biol.200740414316410.1007/978‑1‑59745‑530‑5_8 18450049
     [Google Scholar]
  30. HanH. ChoJ.W. LeeS. YunA. KimH. BaeD. YangS. KimC.Y. LeeM. KimE. LeeS. KangB. JeongD. KimY. JeonH.N. JungH. NamS. ChungM. KimJ.H. LeeI. TRRUST v2: An expanded reference database of human and mouse transcriptional regulatory interactions.Nucleic Acids Res.201846D1D380D38610.1093/nar/gkx1013 29087512
     [Google Scholar]
  31. CuiC. ZhongB. FanR. CuiQ. HMDD v4.0: A database for experimentally supported human microRNA-disease associations.Nucleic Acids Res.202352D1D1327D1332 37650649
     [Google Scholar]
  32. BarbaiT. FejősZ. PuskasL.G. TímárJ. RásóE. The importance of microenvironment: The role of CCL8 in metastasis formation of melanoma.Oncotarget2015630291112912810.18632/oncotarget.5059 26320180
     [Google Scholar]
  33. BatonF. DeruyffelaereC. ChapinM. Prod’hommeT. CharronD. Al-DaccakR. Alcaide-LoridanC. Class II transactivator (CIITA) isoform expression and activity in melanoma.Melanoma Res.200414645346110.1097/00008390‑200412000‑00004 15577315
     [Google Scholar]
  34. KawadaK. SonoshitaM. SakashitaH. TakabayashiA. YamaokaY. ManabeT. InabaK. MinatoN. OshimaM. TaketoM.M. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.Cancer Res.200464114010401710.1158/0008‑5472.CAN‑03‑1757 15173015
     [Google Scholar]
  35. LiaoM. ZengF. LiY. GaoQ. YinM. DengG. ChenX. A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients.Sci. Rep.20201011246210.1038/s41598‑020‑69330‑2 32719391
     [Google Scholar]
  36. AlderdiceM. CraigS.G. HumphriesM.P. GilmoreA. JohnstonN. BinghamV. CoyleV. SenevirathneS. LongleyD.B. LoughreyM.B. McQuaidS. JamesJ.A. Salto-TellezM. LawlerM. McArtD.G. Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer.NAR Genom. Bioinform.202132lqab01610.1093/nargab/lqab016 33928242
     [Google Scholar]
  37. TakeshitaA. ShinjoK. NaitoK. MatsuiH. ShigenoK. NakamuraS. HoriiT. MaekawaM. KitamuraK. NaoeT. OhnishiK. OhnoR. P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As2O3), but are not the main mechanism of As2O3-resistance in acute promyelocytic leukemia cells.Leukemia200317364865010.1038/sj.leu.2402851 12646961
     [Google Scholar]
  38. DingL. YangY. GeY. LuQ. YanZ. ChenX. DuJ. HafiziS. XuX. YaoJ. LiuJ. CaoZ. WeygantN. Inhibition of DCLK1 with DCLK1-IN-1 suppresses renal cell carcinoma invasion and stemness and promotes cytotoxic T-cell-mediated anti-tumor immunity.Cancers20211322572910.3390/cancers13225729 34830884
     [Google Scholar]
  39. DiaoP. JiangY. LiY. WuX. LiJ. ZhouC. JiangL. ZhangW. YanE. ZhangP. DingX. WuH. YuanH. YeJ. SongX. WanL. WuY. JiangH. WangY. ChengJ. Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: Prognostic significance and predictive of therapeutic response.J. Immunother. Cancer202196e00243410.1136/jitc‑2021‑002434 34130988
     [Google Scholar]
  40. GuC. GuX. WangY. YaoZ. ZhouC. Construction and validation of a novel immunosignature for overall survival in uveal melanoma.Front. Cell Dev. Biol.2021971055810.3389/fcell.2021.710558 34552928
     [Google Scholar]
  41. LiS. ZhangR. A novel interactive deep cascade spectral graph convolutional network with multi-relational graphs for disease prediction.Neural Netw.202417510628510.1016/j.neunet.2024.106285 38593556
     [Google Scholar]
  42. HasanbeigM. PavelL. On synchronous binary log-linear learning and second order Q-learning * *This work was supported by an NSERC grant.IFAC-PapersOnLine20175018987899210.1016/j.ifacol.2017.08.1326
     [Google Scholar]
  43. FaghihinejadF. ZoghifardM. AmiriA.M. MonajemS. Evaluating social and spatial equity in public transport: A case study.Transp. Lett.202315101420142910.1080/19427867.2022.2158541
     [Google Scholar]
  44. AhadianP. BabaeiM. ParandK. Using singular value decomposition in a convolutional neural network to improve brain tumor segmentation accuracy.Int. J. Comput. Sci. Inf. Technol.20221416517110.5121/csit.2022.121717
     [Google Scholar]
  45. WangQ. QiaoW. ZhangH. LiuB. LiJ. ZangC. MeiT. ZhengJ. ZhangY. Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma.Front. Immunol.202213101963810.3389/fimmu.2022.1019638 36505501
     [Google Scholar]
  46. XuK. ZhangY. YanZ. WangY. LiY. QiuQ. DuY. ChenZ. LiuX. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis.Front. Immunol.202314120525010.3389/fimmu.2023.1205250 37426643
     [Google Scholar]
  47. ChenH. YangW. LiY. MaL. JiZ. Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients.Front. Immunol.202314119887810.3389/fimmu.2023.1198878 37325625
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073307469240528065718
Loading
Establishing a Ten Disulfidptosis-related Gene Signature for Prognostic Prediction in Skin Cutaneous Melanoma
Comb Chem High Throughput Screen 28, 1952 (2025); https://doi.org/10.2174/0113862073307469240528065718
/content/journals/cchts/10.2174/0113862073307469240528065718
/content/journals/cchts/10.2174/0113862073307469240528065718
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): disulfidptosis; Molecular mechanism; prognosis; RNA-seq; Skin cutaneous melanoma; T cell

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test